1307812-59-4

Basic information

• Product Name: 3-(4-propylphenyl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate
• Synonyms: 3-(4-propylphenyl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate
• CAS NO: 1307812-59-4
• Molecular Weight: 587.463
• Mol File: 1307812-59-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(4-propylphenyl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-propylphenyl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate(1307812-59-4)
• EPA Substance Registry System: 3-(4-propylphenyl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate(1307812-59-4)

Safety Data

• Hazardous Substances Data: 1307812-59-4(Hazardous Substances Data)

Upstream product

• 375-72-4 Nonafluorobutanesulfonyl fluoride 
• 1307809-63-7 3-(4-propylphenyl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-ol 
• 1078-19-9 6-methoxy-3,4-dihydro-1(2H)-naphthalenone 
• 81631-63-2 p-(methoxycarbonyl)-n-propylbenzene 
• 2438-05-3 4-n-propylbenzoic acid 
• 1307812-58-3 7-methoxy-3-(4-propylphenyl)-4,5-dihydronaphtho[1,2-c]isoxazole 
• 54951-36-9 6-methoxy-1-tetralone oxime 

Downstream Products

• 1307812-60-7 3-(4-propylphenyl)-7-vinyl-4,5-dihydronaphtho[1,2-c]isoxazole 
• 1307809-65-9 1-((3-(4-propylphenyl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl)methyl)azetidine-3-carboxylic acid 
• 1307812-61-8 3-(4-propylphenyl)-4,5-dihydronaphtho[1,2-c]isoxazole-7-carbaldehyde 

Relevant articles and documents

TRICYCLIC HETEROCYCLIC COMPOUNDS

Disclosed are compounds of Formula (I) or stereoisomers or salts thereof, wherein: X1, X2, X3, W, Q1, Q2, and G2 are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.